Startup profile · funding coverage
SweetBio funding, valuation and investors
Honey-based wound care biomaterials (APIS®) for clinical healing applications.
Keep track of SweetBio
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Not publicly disclosed
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
Not publicly disclosed
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · Memphis, TN
Overview
SweetBio develops medical-grade honey-incorporated wound care products (APIS) designed for clinical wound management. Based in Memphis, Tennessee, it sits in the city’s medical-device commercialization cluster.
Why SweetBio is interesting
Memphis medtech manufacturing — medical honey wound matrices from the Mid-South device corridor, not another consumer CPG honey brand.
Product & use cases
Regenerative wound care biomaterials incorporating medical honey.
- Chronic wound management
- Surgical wound care settings
Key facts
- Memphis wound-care biomaterials
- APIS honey-based matrices
- Website: sweetbio.com
Competitive landscape
Edge: Honey-based biomaterial approach differentiated from standard collagen dressings.
-
Conventional advanced wound dressings incumbent
Collagen/foam dressing suppliers.
Industries
FAQs about SweetBio
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.